# PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI

> **NCT07343674** · — · RECRUITING · sponsor: **Portuguese Association of Interventional Cardiology** · enrollment: 500 (estimated)

## Conditions studied

- Severe Symptomatic Aortic Stenosis (Defined as New York Heart Association (NYHA) Class ≥ II)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07343674
- **Lead sponsor:** Portuguese Association of Interventional Cardiology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-14
- **Primary completion:** 2027-11
- **Final completion:** 2028-04
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07343674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07343674, "PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07343674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*